Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Duval

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Clinical Pharmacology and Therapeutics|January 22, 2026
Population Pharmacokinetic and Exposure-Efficacy Analysis of Baloxavir Marboxil for Influenza Treatment and Post-Exposure Prophylaxis in ChildrenSylvie Retout, Stefan De Buck, Jacques Gaudreault, et al.
Anticancer Research|October 30, 2016
Phase I Study of the Pan-PI3K Inhibitor Buparlisib in Adult Chinese Patients with Advanced Solid TumorsYi-Long Wu, L I Zhang, Lucia Trandafir, et al.
Antimicrobial Agents and Chemotherapy|April 22, 2020
Population Pharmacokinetics and Exposure-Response Relationships of Baloxavir Marboxil in Influenza Patients at High Risk of ComplicationsHiroki Koshimichi, Sylvie Retout, Valerie Cosson, et al.
Clinical and Translational Science|February 17, 2022
Pharmacokinetics, safety, and simulated efficacy of an influenza treatment, baloxavir marboxil, in Chinese individualsYanmei Liu, Sylvie Retout, Vincent Duval, et al.
Clinical Pharmacokinetics|November 9, 2010
Pharmacokinetics and pharmacodynamics of single rising intravenous doses (0.5 mg-10 mg) and determination of absolute bioavailability of the dipeptidyl peptidase-4 inhibitor linagliptin (BI 1356) in healthy male subjectsSilke Retlich, Vincent Duval, Arne Ring, et al.
International Journal of Molecular Sciences|September 23, 2022
Identification of Adipose Tissue as a Reservoir of Macrophages after Acute Myocardial InfarctionIngrid Gomez, Virginie Robert, Paul Alayrac, et al.
Journal of Drugs in Dermatology : JDD|October 6, 2023
Selection of Nemolizumab Clinical Dosage for Atopic DermatitisNathalie Wagner, Luca Loprete, Vincent Duval, et al.
Journal of the American College of Cardiology|February 18, 2022
Splenic Marginal Zone B Lymphocytes Regulate Cardiac Remodeling After Acute Myocardial Infarction in MiceYanyi Sun, Cristina Pinto, Stéphane Camus, et al.
Antimicrobial Agents and Chemotherapy|September 13, 2021
Population Pharmacokinetics, Exposure-Response, and Probability of Target Attainment Analyses for Tedizolid in Adolescent Patients with Acute Bacterial Skin and Skin Structure InfectionsDan Li, Philip E Sabato, Benjamin Guiastrennec, et al.
Clinical Pharmacology and Therapeutics|October 1, 2023
Population Pharmacokinetics and Exposure-Response Analysis for the CTLA-4 Inhibitor Tremelimumab in Metastatic NSCLC Patients in the Phase III POSEIDON StudyJimmy Zhijian He, Vincent Duval, Petra Jauslin, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Clinical Pharmacology and Therapeutics|January 22, 2026
Population Pharmacokinetic and Exposure-Efficacy Analysis of Baloxavir Marboxil for Influenza Treatment and Post-Exposure Prophylaxis in ChildrenSylvie Retout, Stefan De Buck, Jacques Gaudreault, et al.
Anticancer Research|October 30, 2016
Phase I Study of the Pan-PI3K Inhibitor Buparlisib in Adult Chinese Patients with Advanced Solid TumorsYi-Long Wu, L I Zhang, Lucia Trandafir, et al.
Antimicrobial Agents and Chemotherapy|April 22, 2020
Population Pharmacokinetics and Exposure-Response Relationships of Baloxavir Marboxil in Influenza Patients at High Risk of ComplicationsHiroki Koshimichi, Sylvie Retout, Valerie Cosson, et al.
Clinical and Translational Science|February 17, 2022
Pharmacokinetics, safety, and simulated efficacy of an influenza treatment, baloxavir marboxil, in Chinese individualsYanmei Liu, Sylvie Retout, Vincent Duval, et al.
Clinical Pharmacokinetics|November 9, 2010
Pharmacokinetics and pharmacodynamics of single rising intravenous doses (0.5 mg-10 mg) and determination of absolute bioavailability of the dipeptidyl peptidase-4 inhibitor linagliptin (BI 1356) in healthy male subjectsSilke Retlich, Vincent Duval, Arne Ring, et al.
International Journal of Molecular Sciences|September 23, 2022
Identification of Adipose Tissue as a Reservoir of Macrophages after Acute Myocardial InfarctionIngrid Gomez, Virginie Robert, Paul Alayrac, et al.
Journal of Drugs in Dermatology : JDD|October 6, 2023
Selection of Nemolizumab Clinical Dosage for Atopic DermatitisNathalie Wagner, Luca Loprete, Vincent Duval, et al.
Journal of the American College of Cardiology|February 18, 2022
Splenic Marginal Zone B Lymphocytes Regulate Cardiac Remodeling After Acute Myocardial Infarction in MiceYanyi Sun, Cristina Pinto, Stéphane Camus, et al.
Antimicrobial Agents and Chemotherapy|September 13, 2021
Population Pharmacokinetics, Exposure-Response, and Probability of Target Attainment Analyses for Tedizolid in Adolescent Patients with Acute Bacterial Skin and Skin Structure InfectionsDan Li, Philip E Sabato, Benjamin Guiastrennec, et al.
Clinical Pharmacology and Therapeutics|October 1, 2023
Population Pharmacokinetics and Exposure-Response Analysis for the CTLA-4 Inhibitor Tremelimumab in Metastatic NSCLC Patients in the Phase III POSEIDON StudyJimmy Zhijian He, Vincent Duval, Petra Jauslin, et al.
Pageof 3